FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ursula Sorg

Research Profile

Anatomy

Chemicals & Drugs

Physiology

Living Beings

Procedures

Disorders

DNA Damage

Co-author Network

Publications

TOP 3
Veronika Kleff; Ursula R Sorg; Carsten Bury; Takuji Suzuki; Ina Rattmann; Moran Jerabek-Willemsen; Christopher Poremba; Michael Flasshove; Bertram Opalka; Bruce Trapnell; Uta Dirksen; Thomas Moritz
Gene therapy of beta(c)-deficient pulmonary alveolar proteinosis (beta(c)-PAP): studies in a murine in vivo model.
Jan Dürig; Peter Ebeling; Florian Grabellus; Ursula R Sorg; Michael Möllmann; Philipp Schütt; Joachim Göthert; Ludger Sellmann; Siegfried Seeber; Michael Flasshove; Ulrich Dührsen; Thomas Moritz
A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease.
Ursula R Sorg; Veronika Kleff; Sepideh Fanaei; Alexandra Schumann; Michael Moellmann; Bertram Opalka; Jürgen Thomale; Thomas Moritz
O6-methylguanine-DNA-methyltransferase (MGMT) gene therapy targeting haematopoietic stem cells: studies addressing safety issues.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ursula Sorg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Veronika Kleff; Ursula R Sorg; Carsten Bury; Takuji Suzuki; Ina Rattmann; Moran Jerabek-Willemsen; Christopher Poremba; Michael Flasshove; Bertram Opalka; Bruce Trapnell; Uta Dirksen; Thomas Moritz
Gene therapy of beta(c)-deficient pulmonary alveolar proteinosis (beta(c)-PAP): studies in a murine in vivo model.
Molecular therapy : the journal of the American Society of Gene Therapy 2008;16(4):757-64.
2007: Jan Dürig; Peter Ebeling; Florian Grabellus; Ursula R Sorg; Michael Möllmann; Philipp Schütt; Joachim Göthert; Ludger Sellmann; Siegfried Seeber; Michael Flasshove; Ulrich Dührsen; Thomas Moritz
A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease.
Cancer research 2007;67(18):8653-61.
2007: Ursula R Sorg; Veronika Kleff; Sepideh Fanaei; Alexandra Schumann; Michael Moellmann; Bertram Opalka; Jürgen Thomale; Thomas Moritz
O6-methylguanine-DNA-methyltransferase (MGMT) gene therapy targeting haematopoietic stem cells: studies addressing safety issues.
DNA repair 2007;6(8):1197-209.
2007: Peter Ebeling; P Bach; Ursula R Sorg; A Schneider; Tanja Trarbach; Dagmar Dilloo; Helmut Hanenberg; S Niesert; Siegfried Seeber; Thomas Moritz; Michael Flasshove
Evaluation of different protocols for gene transfer into non-obese diabetes/severe combined immunodeficiency disease mouse repopulating cells.
Journal of cancer research and clinical oncology 2007;133(3):199-209.
2007: Ina Rattmann; Veronika Kleff; Anja Feldmann; Carsten Ludwig; Ursula R Sorg; Bertram Opalka; Thomas Moritz; Michael Flasshove
Reliable generation of stable high titer producer cell lines for gene therapy.
Intervirology 2007;50(3):197-203.
2006: Ina Rattmann; Veronika Kleff; Ursula R Sorg; Walter Bardenheuer; Annette Brueckner; Ralf A Hilger; Bertram Opalka; Siegfried Seeber; Michael Flasshove; Thomas Moritz
Gene transfer of cytidine deaminase protects myelopoiesis from cytidine analogs in an in vivo murine transplant model.
Blood 2006;108(9):2965-71.
2006: Tomke U Bracker; Bernd Giebel; Jan Spanholtz; Ursula R Sorg; Ludger Klein-Hitpass; Thomas Moritz; Jürgen Thomale
Stringent regulation of DNA repair during human hematopoietic differentiation: a gene expression and functional analysis.
Stem cells (Dayton, Ohio) 2006;24(3):722-30.
2005: Walter Bardenheuer; K Lehmberg; Ina Rattmann; A Brueckner; A Schneider; Ursula R Sorg; Siegfried Seeber; Thomas Moritz; Michael Flasshove
Resistance to cytarabine and gemcitabine and in vitro selection of transduced cells after retroviral expression of cytidine deaminase in human hematopoietic progenitor cells.
Leukemia 2005;19(12):2281-8.
2003: Roland Meisel; Walter Bardenheuer; Claudia Strehblow; Ursula R Sorg; Ahmet H Elmaagacli; Siegfried Seeber; Michael Flasshove; Thomas Moritz
Efficient protection from methotrexate toxicity and selection of transduced human hematopoietic cells following gene transfer of dihydrofolate reductase mutants.
Experimental hematology 2003;31(12):1215-22.
2002: Michael Jansen; Ursula R Sorg; Susanne Ragg; Michael Flasshove; Siegfried Seeber; David A Williams; Thomas Moritz
Hematoprotection and enrichment of transduced cells in vivo after gene transfer of MGMT(P140K) into hematopoietic stem cells.
Cancer gene therapy 2002;9(9):737-46.
2001: M Jansen; Walter Bardenheuer; Ursula R Sorg; Siegfried Seeber; Michael Flasshove; Thomas Moritz
Protection of hematopoietic cells from O(6)-alkylation damage by O(6)-methylguanine DNA methyltransferase gene transfer: studies with different O(6)-alkylating agents and retroviral backbones.
European journal of haematology 2001;67(1):2-13.